Literature DB >> 10520632

Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association.

C Bull1.   

Abstract

BACKGROUND: Assessment of the effect of fetal diagnosis on the prevalence of congenital heart disease at term requires national ascertainment because referral patterns are not rigorously structured.
METHODS: Between 1993 and 1995, all 17 paediatric cardiac centres in the UK submitted to a database lists of all fetuses diagnosed, and all infants needing surgery or interventional catheterisation or dying in the first year of life because of structural heart disease; details included the postal area of residence.
FINDINGS: There were 4799 affected pregnancies, 4165 babies born alive, 1124 fetal diagnoses, and 567 terminations of pregnancy because the fetus had structural heart disease. Thus, a fetal diagnosis was made in 23.4% of affected pregnancies (11.7% of all affected livebirths) with geographical variability in diagnostic rates.
INTERPRETATION: Fetal cardiac screening has an effect on the prevalence and types of congenital heart disease seen at term because many affected pregnancies are terminated. If detection rates of affected fetuses rose nationally to those seen in the 15 postal areas where detection rates were significantly higher than the national average in 1993-95, we would expect about 218 fewer affected individuals to be born annually.

Entities:  

Mesh:

Year:  1999        PMID: 10520632     DOI: 10.1016/s0140-6736(99)01167-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  54 in total

1.  Management of the neonate with symptomatic congenital heart disease.

Authors:  D J Penny; L S Shekerdemian
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 2.  Fetal echocardiography: 20 years of progress.

Authors:  H M Gardiner
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Screening for Down's syndrome. Antenatal screening has human costs.

Authors:  Josephine Venn-Treloar
Journal:  BMJ       Date:  2002-01-12

4.  Prenatal diagnosis of structural heart disease: does it make a difference to survival?

Authors:  I D Sullivan
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

5.  Prenatal diagnosis of pulmonary atresia: impact on clinical presentation and early outcome.

Authors:  Aphrodite Tzifa; Claire Barker; Shane M Tibby; John M Simpson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-07-13       Impact factor: 5.747

Review 6.  Transporting babies with known heart disease; who, what and where?

Authors:  Frances A Bu'Lock
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03       Impact factor: 5.747

Review 7.  Recent advances in neonatal cardiac surgery.

Authors:  Chawki el-Zein; Michel N Ilbawi
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

Review 8.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

9.  Improving the effectiveness of routine prenatal screening for major congenital heart defects.

Authors:  J S Carvalho; E Mavrides; E A Shinebourne; S Campbell; B Thilaganathan
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 10.  Prenatal diagnosis and treatment planning of congenital heart defects-possibilities and limits.

Authors:  Mathias Nelle; Luigi Raio; Mladen Pavlovic; Thierry Carrel; Daniel Surbek; Matthias Meyer-Wittkopf
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.